🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › Alabama › Birmingham

Qorannoo klinikaalii Myelofibrosis Birmingham, AL keessatti

Qorannoo 7 Myelofibrosis f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Alabama, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • University of Alabama At Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

Namoota walitti qabaa jiraSadarkaa 1
  • University of Alabama at Birmingham, Birmingham
4 Weeks – 75 Years · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06047886

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 2
  • University of Alabama Birmingham, Birmingham
Umuriin 18 hanga 66 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06859424

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Birmingham
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 3
  • UAB Hospital, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06479135

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Alabama at Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Gur-2023 · NCT05280509

Qorannoo Myelofibrosis magaalota biroo keessatti

Qorannoo biroo Birmingham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.